Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A

Paola Cassoni, Anna Sapino, Nicoletta Fortunati, Luca Munaron, Bice Chini, Gianni Bussolati

Research output: Contribution to journalArticle

Abstract

Oxytocin (OT) inhibits the proliferation of breast-cancer cells in vitro via a specific G-coupled receptor. To elucidate the intracellular mechanism involved in this biological effect, different G-coupled receptor mediators have been investigated in untreated and OT-treated MDA-MB231 breast-carcinoma cells, in these cells, after OT treatment, a significant cAMP increase was observed using a radioimmunoassay procedure, whereas the Ca2+ (determined with the fluorescent probe fura-2) and the inositol phosphate (determined after cell labeling with myo(2-3H)-inositol) concentrations were not modified, contrary to what has been observed in myometrial and myo-epithelial cells. The PKA inhibitor PKI (6-22) amide reverted the effect of OT, indicating that the anti-proliferative effect of the peptide is strictly related to the cAMP-PKA pathway. OT treatment did not modify tyrosine phosphorylation either. Our results indicate that in breast epithelial cells devoid of contractile activity, cAMP is the intracellular mediator of OT action, whereas the Ca2+-phosphoinositide system is not involved.

Original languageEnglish
Pages (from-to)340-344
Number of pages5
JournalInternational Journal of Cancer
Volume72
Issue number2
DOIs
Publication statusPublished - Jul 17 1997

Fingerprint

Adenosine Kinase
Oxytocin
Cyclic AMP-Dependent Protein Kinases
Breast Neoplasms
Epithelial Cells
Inositol Phosphates
Fura-2
Inositol
Phosphatidylinositols
Fluorescent Dyes
Radioimmunoassay
Tyrosine
Breast
Phosphorylation
Peptides

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. / Cassoni, Paola; Sapino, Anna; Fortunati, Nicoletta; Munaron, Luca; Chini, Bice; Bussolati, Gianni.

In: International Journal of Cancer, Vol. 72, No. 2, 17.07.1997, p. 340-344.

Research output: Contribution to journalArticle

Cassoni, Paola ; Sapino, Anna ; Fortunati, Nicoletta ; Munaron, Luca ; Chini, Bice ; Bussolati, Gianni. / Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. In: International Journal of Cancer. 1997 ; Vol. 72, No. 2. pp. 340-344.
@article{c96cb4bd1ce548bc8019d1eb32588bff,
title = "Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A",
abstract = "Oxytocin (OT) inhibits the proliferation of breast-cancer cells in vitro via a specific G-coupled receptor. To elucidate the intracellular mechanism involved in this biological effect, different G-coupled receptor mediators have been investigated in untreated and OT-treated MDA-MB231 breast-carcinoma cells, in these cells, after OT treatment, a significant cAMP increase was observed using a radioimmunoassay procedure, whereas the Ca2+ (determined with the fluorescent probe fura-2) and the inositol phosphate (determined after cell labeling with myo(2-3H)-inositol) concentrations were not modified, contrary to what has been observed in myometrial and myo-epithelial cells. The PKA inhibitor PKI (6-22) amide reverted the effect of OT, indicating that the anti-proliferative effect of the peptide is strictly related to the cAMP-PKA pathway. OT treatment did not modify tyrosine phosphorylation either. Our results indicate that in breast epithelial cells devoid of contractile activity, cAMP is the intracellular mediator of OT action, whereas the Ca2+-phosphoinositide system is not involved.",
author = "Paola Cassoni and Anna Sapino and Nicoletta Fortunati and Luca Munaron and Bice Chini and Gianni Bussolati",
year = "1997",
month = "7",
day = "17",
doi = "10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I",
language = "English",
volume = "72",
pages = "340--344",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A

AU - Cassoni, Paola

AU - Sapino, Anna

AU - Fortunati, Nicoletta

AU - Munaron, Luca

AU - Chini, Bice

AU - Bussolati, Gianni

PY - 1997/7/17

Y1 - 1997/7/17

N2 - Oxytocin (OT) inhibits the proliferation of breast-cancer cells in vitro via a specific G-coupled receptor. To elucidate the intracellular mechanism involved in this biological effect, different G-coupled receptor mediators have been investigated in untreated and OT-treated MDA-MB231 breast-carcinoma cells, in these cells, after OT treatment, a significant cAMP increase was observed using a radioimmunoassay procedure, whereas the Ca2+ (determined with the fluorescent probe fura-2) and the inositol phosphate (determined after cell labeling with myo(2-3H)-inositol) concentrations were not modified, contrary to what has been observed in myometrial and myo-epithelial cells. The PKA inhibitor PKI (6-22) amide reverted the effect of OT, indicating that the anti-proliferative effect of the peptide is strictly related to the cAMP-PKA pathway. OT treatment did not modify tyrosine phosphorylation either. Our results indicate that in breast epithelial cells devoid of contractile activity, cAMP is the intracellular mediator of OT action, whereas the Ca2+-phosphoinositide system is not involved.

AB - Oxytocin (OT) inhibits the proliferation of breast-cancer cells in vitro via a specific G-coupled receptor. To elucidate the intracellular mechanism involved in this biological effect, different G-coupled receptor mediators have been investigated in untreated and OT-treated MDA-MB231 breast-carcinoma cells, in these cells, after OT treatment, a significant cAMP increase was observed using a radioimmunoassay procedure, whereas the Ca2+ (determined with the fluorescent probe fura-2) and the inositol phosphate (determined after cell labeling with myo(2-3H)-inositol) concentrations were not modified, contrary to what has been observed in myometrial and myo-epithelial cells. The PKA inhibitor PKI (6-22) amide reverted the effect of OT, indicating that the anti-proliferative effect of the peptide is strictly related to the cAMP-PKA pathway. OT treatment did not modify tyrosine phosphorylation either. Our results indicate that in breast epithelial cells devoid of contractile activity, cAMP is the intracellular mediator of OT action, whereas the Ca2+-phosphoinositide system is not involved.

UR - http://www.scopus.com/inward/record.url?scp=0030745683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030745683&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I

DO - 10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I

M3 - Article

C2 - 9219843

AN - SCOPUS:0030745683

VL - 72

SP - 340

EP - 344

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -